ICON and Oxford Outcomes experts will speak at 14 educational sessions on a range of topics, including observational research, advanced decision modelling on health economic evaluations, optimum methods for PRO translation and linguistic validation, and comparative effectiveness research. Also at the event, Dr. Mark Sculpher, Senior Scientific Consultant, Health Economics at Oxford Outcomes, will address the meeting as the incoming President of ISPOR.
Attendees will be able to meet ICON and Oxford Outcomes senior executives by visiting the ICON booth (#66) in the exhibit hall.
ICON acquired Oxford Outcomes in January 2011. Together with Oxford Outcomes, ICON offers a broad suite of services in Late Phase and Outcomes Research supporting the pharmaceutical, biotechnology, consumer medicine, medical device and diagnostics industries.
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has around 7,100 employees, operating from 77 locations in 38 countries.
Further information is available at www.iconplc.com
Contacts
Weber Shandwick
Genevieve Tuck
Gtuck@webershandwick.com
+44 (0) 2070 670 655
